Swissmedic Vigilance News Edition 21 – November 2018
In this edition: Isotretinoin and DOAC – Updates Confusion between amphotericin B formulations Guest articles: RPVC Zurich and RPVC Ticino Quality Assurance in Transfusion Practice Statistical Review 2017
In this edition:
Isotretinoin and DOAC – Updates
Confusion between amphotericin B formulations
Guest articles: RPVC Zurich and RPVC Ticino
Quality Assurance in Transfusion Practice
Statistical Review 2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Figure 3: Prescriber of quetiapine (Ntot=476)<br />
Conclusion<br />
The results confirm that quetiapine is widely<br />
used in retirement homes in Ticino: A third<br />
of the residents are treated with this medicine.<br />
Quetiapine was administered mainly at<br />
low dosages for an off-label indication, particularly<br />
for the treatment of agitation and<br />
dementia.<br />
A statistically significant link also emerged<br />
between the off-label prescribing of quetiapine<br />
and the prescribing by general practitioners<br />
compared to specialists.<br />
Efforts to raise awareness among general<br />
practitioners about the off-label use of quetiapine<br />
and, possibly, the increased involvement<br />
of specialists in the prescribing of<br />
drugs in retirement homes may help reduce<br />
the frequency of prescription of this drug in<br />
inappropriate cases, and thereby improve<br />
the care of the elderly.<br />
Literature<br />
(1) Alexander GC, Gallagher SA, Mascola A, Moloney<br />
RM, Stafford RS. Increasing off-label use of antipsychotic<br />
medications in the United States, 1995-<br />
2008. Pharmacoepidemiol Drug Saf. 2011<br />
Feb;20(2):177-84<br />
(2) McKean A, Monasterio E. Indications of atypical<br />
antipsychotics in the elderly. Expert Rev Clin Pharmacol.<br />
2015 Jan;8(1):5-7.<br />
(3) McKean A, Monasterio E. Off-label use of atypical<br />
antipsychotics: cause for concern? CNS Drugs.<br />
2012 May 1;26(5):383-90.<br />
(4) Maglione M, Maher AR, Hu J, Wang Z, Shanman<br />
R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, E-<br />
wing BA, Motala A, Perry T. Off-Label Use of Atypical<br />
Antipsychotics: An Update [Internet]. Rockville<br />
(MD): Agency for Healthcare Research and<br />
Quality (US); 2011 Sep.<br />
(5) Brett J. Concerns about quetiapine. Aust Prescr.<br />
2015 Jun;38(3):95-7.<br />
(6) Pharmaceutical Care Research Group (www.imailoffizin.ch),<br />
Les indications off-label de la quétiapine,<br />
2015.<br />
(7) El-Saifi N, Moyle W, Jones C, Tuffaha H. Quetiapine<br />
safety in older adults: a systematic literature<br />
review. J Clin Pharm Ther. 2016 Feb;41(1):7-18.<br />
<strong>Swissmedic</strong> <strong>Vigilance</strong> <strong>News</strong> | <strong>Edition</strong> <strong>21</strong> <strong>–</strong> <strong>November</strong> <strong>2018</strong> 25 | 39